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Abstract The heavy chain (Hc) and light chain (Lc) genes of the
Fab fragment of a catalytic antibody 6D9 were simultaneously
expressed in an Escherichia coli in vitro transcription/translation
system without a reducing agent. The intermolecular disulfide
bond between the Hc and Lc was found formed, suggesting a
correct formation of the Fab fragment in the in vitro system. In
enzyme-linked immunosorbent assay, the Fab fragment synthe-
sized in vitro exhibited an antigen-binding activity. Addition of
reduced glutathione, oxidized glutathione, protein disulfide-
isomerase and molecular chaperones, GroEL and GroES,
increased the solubility and the antigen-binding activity of the
Fab fragment greatly. The in vitro synthesized Fab was purified
by means of a hexa-histidine tag attached to the C-terminus of
the Hc. Catalytic assay of the purified Fab fragment showed
that the His-tagged Fab fragment synthesized in vitro had a
catalytic activity comparable to that produced in vivo. ß 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Since a complete antibody such as IgG is a large molecule,
much smaller functional domains (Fv, Fab fragments) retain-
ing antigen-binding activity can be applied for a number of
practical uses [1,2]. Recent progress in genetic and antibody
engineering has made it possible to produce various antibody
fragments carrying desirable properties [3]. In addition, as an
alternative to the hybridoma technology, cDNA of antibodies
can be ampli¢ed using appropriate primers, cloned into an
expression vector, and synthesized as these small molecules
in recombinant Escherichia coli to obtain new antibody mol-
ecules [4^8].
Because of the small size and useful properties, single-chain
Fv (scFv), which is composed of the variable heavy chain
(Hc), a linker and the variable light chain (Lc), has been
used in a wide range of systems such as phage display and
in vivo expression [9,10]. These two variable domains are ar-
ti¢cially interconnected by a £exible peptide linker, which is,
however, sometimes degraded by proteases, resulting in the
dissociation of the two chains. Moreover, the a⁄nity of an
original antibody was sometimes impaired in the correspond-
ing scFv [11].
Recently, cell-free protein synthesis systems have been used
as an alternative method of producing proteins from cloned
genes. This system o¡ers many potential advantages. It can be
free from inclusion body formation that sometimes occurs
when recombinant proteins are expressed in microbial cells
[12]. In addition, two genes can be simultaneously transcribed
and translated in an E. coli in vitro coupled transcription/
translation system, and the two synthesized products can
also act on each other [13]. However, only scFv has been
reported to be synthesized in the in vitro systems [14,15],
and there is no paper describing the Fab fragment formation
by a cell-free protein synthesis system until now.
In this report, we describe that a Fab fragment was able to
be synthesized in an active form by an E. coli in vitro coupled
transcription/translation system. The genes encoding the indi-
vidual chains (Hc and Lc) of the Fab fragment of catalytic
antibody 6D9 [11,16] were separately cloned into a T7 expres-
sion vector. Both of these plasmids were used as templates for
the in vitro system without reducing agent. The synthesized
Hc and Lc folded successively to form a Fab fragment with
the intermolecular disul¢de bond of Hc and Lc showing cata-
lytic as well as binding activity.
2. Materials and methods
2.1. Plasmid construction
The Hc gene was ampli¢ed using a set of primers (Hc-1: 5P-
GGGAATTCCATATGCAGGTGCAGCTGCTCGAGTCT-3P (NdeI
site is underlined) and ARA-R: 5P-CTTCTCTCATCCGCCAAAA-
CAGCC-3P) from the plasmid pARA-6D9Fab [11]. The polymerase
chain reaction (PCR) product was digested with NdeI^KpnI, and
cloned into the NdeI^KpnI site of pRSET-B vector (Invitrogen). The
resultant plasmid was designated as pRSET-6D9Hc and used for the
expression of Hc of 6D9 under the control of the T7 promoter.
The gene of Lc was ampli¢ed using Lc-1: 5P-GGGAATTCCA-
TATGGAGCTCGTGATGACCCAGACTC-3P (NdeI site is under-
lined) and ARA-R from the plasmid pARA-6D9Fab. The PCR prod-
uct was digested with NdeI and HindIII, and cloned into the pRSET-
B vector with the NdeI^HindIII site, resulting in pRSET-6D9Lc.
In addition, the Hc gene was ampli¢ed using Hc-1 and Hc-2: 5P-
CCCAAGCTTACTAGTACAATCCCTGGGCACAATTTT-3P (Hin-
dIII site is underlined). The PCR product was digested with NdeI^
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HindIII and inserted into the NdeI^HindIII site of pET23b vector
(Novagen). The resulting plasmid, pET23b-6D9Hc, contained 6D9
Hc and six histidines at the C-terminus.
E. coli DH5K was used as the host for the DNA manipulator.
Nucleic acid sequences of the cloned region of each plasmid were
checked with Thermo Sequenase1 II dye terminator cycle sequencing
premix kit (Amersham Pharmacia Biotech) and ABIPRISM1 310
Genetic Analyzer, according to the recommended protocols.
2.2. In vitro coupled transcription/translation
The in vitro coupled transcription/translation system was essentially
the same as described previously [17]. Each template DNA of a ¢nal
concentration of 20 Wg/ml was transcribed and translated at 30‡C in a
30 Wl mixture (56.4 mM Tris^acetate, pH 7.4; 1.2 mM ATP; 1.0 mM
each of GTP, CTP, and UTP; 40 mM creatine phosphate; 0.32 mM
each, all 20 kinds of unlabeled amino acids; 4% (w/v) polyethylene
glycol 6000; 34.6 Wg/ml folinic acid; 0.17 mg/ml E. coli tRNAs; 36
mM ammonium acetate; 8 mM Mg(OAc)2 ; 100 mM KOAc; 10 Wg/ml
rifampicin; 0.15 mg/ml creatine kinase; 7.7 Wg/ml T7 RNA polymer-
ase; and 28.3% (v/v) S30 extract).
The T7 RNA polymerase was puri¢ed from E. coli BL21/pREP4/
pQE-T7P [18], which was a kind gift from Dr. T. Suzuki. The S30
extracts were prepared from E. coli A19, according to the procedure
of Pratt [19] with some modi¢cations as described previously [17]. 14C-
Labeled leucine was added to the reaction system at a concentration
of 0.016 mM for autoradiography.
Protein disul¢de-isomerase (PDI) from Humicola iosolens [20],
which was kindly provided by Toyota Central Research and Develop-
ment Laboratories, was used at a ¢nal concentration of 36 Wg/ml.
Glutathione in the reduced (GSH) and oxidized (GSSG) forms was
used at a concentration of 0.1 and 1 mM, respectively. The concen-
trations of the chaperones in the reaction mixture were as follows:
DnaJ, GroEL (TaKaRa, Japan) and GroES (TaKaRa, Japan) 0.4 WM
each, and DnaK 1.4 WM. The DnaJ and DnaK were puri¢ed from E.
coli DH5K/pMAL-C2-DnaJ and E. coli DH5K/pMAL-C2-DnaK [21],
respectively, which were kind gifts from Dr. A. Kondo.
2.3. Analysis of solubility of protein synthesized in vitro
After transcription/translation, samples were centrifuged at 15 000
rpm for 5 min to separate soluble (supernatant) and precipitated (pel-
let) fractions. The pellet was resuspended in the original volume of
distilled water. Synthesized proteins existing in the supernatant and in
the pellet are de¢ned as soluble and precipitated forms, respectively.
2.4. Sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) and autoradiography
Typically 5 Wl of the samples was boiled with an equal volume of
either loading bu¡er (50 mM Tris^HCl, pH 6.8, 10% glycerol, 2%
SDS, and 0.1% bromophenol blue) for non-reducing conditions, or
the loading bu¡er plus 2% 2-mercaptoethanol for reducing conditions.
The boiled samples were electrophoresed on SDS^12.5% polyacryl-
amide gel, followed by autoradiography.
2.5. Enzyme-linked immunosorbent assay (ELISA)
Falcon Pro-Bind1 assay plates (96-well, Becton Dickinson Lab-
ware) were coated with a hapten^bovine serum albumin (BSA) con-
jugate (50 Wl/well, [16]). This hapten was used at 5 Wg/ml in 20 mM
phosphate-bu¡ered saline (PBS) (3.12 g/l NaH2PO4, 8.8 g/l NaCl, pH
7.4), and its structure is shown in Fig. 1. After incubation at 4‡C
overnight, the wells were blocked at 37‡C for 30 min by 1/4UBlock
Ace in distilled water (Dainihon Pharmaceutical, Osaka, Japan), and
washed twice with a washing solution (1/10UBlock Ace, 0.05% Tween
20). Cell-free reaction mixtures (30 Wl aliquots) were diluted 2000-fold
by PBS (pH 7.4). This diluted solution of 50 Wl was added into the
precoated plate, incubated at 25‡C for 2 h, then washed twice with the
same washing solution. At the same time, reaction mixtures without
DNA template were used for control reactions. Biotinylated anti-
mouse IgG (H+L) of 150 Wl (5 Wg/ml in distilled water; Vector Labo-
ratories, CA, USA) was added to each one and incubated at 25‡C for
1 h. After washing twice, ELISA was performed using the Vectastain
ABC kit (Vector Laboratories) according to the supplier’s protocol.
The solution containing o-phenylenediamine and H2O2 was used as
the substrate for the peroxidase reaction. The color reaction was
stopped by using 2 M H2SO4. Absorbance was measured at 492 nm.
2.6. Puri¢cation of Fab synthesized in vitro
In order to purify His-tagged Fab, a HiTrap chelating column of
1 ml (Amersham Pharmacia Biotech) was used. The column was sa-
turated with Ni2 ions by using 0.1 M NiSO4, and then washed with
distilled water until Ni2 was eluted. The samples were centrifuged at
10 000Ug for 60 min at 4‡C and the supernatant was applied to the
column equilibrated with the bu¡er (50 mM HEPES^KOH, pH 7.6,
1 M NH4Cl, 10 mM MgCl2). The His-tagged Fab was eluted by a
linear gradient of imidazole (pH 7.6) from 0 to 500 mM at a £ow rate
of 2 ml/min. The eluted fraction was concentrated and the bu¡er was
exchanged to 50 mM Tris^HCl (pH 8.0) by using Ultrafree-0.5 Cen-
trifugal Filter Units (Millipore). The protein concentration was deter-
mined by measuring the absorbance at 595.5 nm using the Bio-Rad
Protein Assay kit (Bio-Rad Laboratories, CA, USA) with BSA as
standard. The His-tagged Hc synthesized in vitro was also puri¢ed
by the same method.
2.7. Hydrolytic activity assay
Catalytic activity of 6D9 Fab synthesized in vitro was examined in
the hydrolysis of 200 WM substrate shown in Fig. 2 [16], with 2 WM
Fab in 50 mM Tris^HCl (pH 8.0) at 25‡C. The reaction was initiated
by adding 2 Wl of a stock solution of the substrate in dimethyl sulf-
oxide to 18 Wl of puri¢ed Fab solution. The high-performance liquid
chromatography (HPLC) analysis was performed using a CAPCELL
PAK C18 UG80 S-5 column (4.6U250 mm, Shiseido, Tokyo, Japan)
eluted with CH3CN/0.1% aqueous tri£uoroacetic acid at a £ow rate of
1.0 ml/min with detection at 278 nm. The activities of the 6D9 Fab
Fig. 1. Structure of hapten used for ELISA assay.
Fig. 2. Antibody-catalyzed reaction. The chloramphenicol monoester, substrate (I), was used for the assays of the antibody-catalyzed reaction.
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fragment produced in vivo and puri¢ed by Miyashita et al. [11] and
the puri¢ed His-tagged Hc were also analyzed by HPLC as control.
3. Results and discussion
3.1. Synthesis of 6D9 Fab fragment in the E. coli in vitro
coupled transcription/translation system
The cell-free translation system normally contains a reduc-
ing reagent such as dithiothreitol to keep the reduced reaction
conditions similar to inside a living cell. In order to express
the Fab fragment, however, the normal conditions seem in-
appropriate because disul¢de bridges that are necessary to
express the functional Fab cannot be formed under such re-
ducing conditions. Therefore, plasmids pRSET-6D9Hc and
pRSET-6D9Lc, carrying Hc and Lc genes, respectively, of
the Fab fragment of catalytic antibody 6D9, served as tem-
plates in the E. coli in vitro coupled transcription/translation
system without a reducing agent as described in Section 2. The
synthesized proteins were analyzed by 12.5% SDS^PAGE
under non-reducing conditions and autoradiography. When
these two plasmids were used separately, the autoradiography
showed that Hc and Lc of 6D9 could be detected as clear
bands in the gel with molecular masses of about 26 and 24
kDa, respectively (Fig. 3). When these two plasmids were put
into the same reaction tube, in addition to bands from Hc and
Lc genes, a new band with an approximate molecular mass of
50 kDa appeared on the gel (Fig. 3). The 50 kDa band was
not observed in the early stage of the reaction, but became
visible after 20 min of the reaction and intensi¢ed afterward
(Fig. 4).
These results suggest that the synthesized Hc and Lc have a
natural tendency to connect each other with the interchain
disul¢de bond, resulting in the formation of a Fab fragment
in the E. coli in vitro coupled transcription/translation system
without reducing agent. In addition, the synthesized Fab frag-
ment seemed to be stable, since no degradation was observed
during a long incubation period (up to 180 min, Fig. 4).
3.2. Antigen recognition of 6D9 Fab fragment synthesized in
vitro
To determine whether this 6D9 Fab fragment synthesized in
vitro possesses a correct conformation for antigen-binding,
ELISA was carried out against hapten^BSA. As seen in Fig.
5, the ELISA signal of the Fab fragment was signi¢cantly as
high as 0.13. On the other hand, the signals of the Lc and the
Hc were below detection levels. These results strongly suggest
that the Fab fragment synthesized in vitro was capable of
binding the corresponding antigen.
3.3. E¡ects of redox potential, PDI and molecular chaperones
on the solubility and binding activity of 6D9 Fab fragment
In addition to the interchain disul¢de bond, the Fab frag-
ment has also intrachain disul¢de bonds within each of the
four domains. The conserved intrachain disul¢de bond is sup-
posed to be critical for the stability and the activity of anti-
body domains [22,23], and its formation is a slow process
because the cysteine residues are buried in the interior of
the protein molecule [24]. Therefore, to minimize the aggrega-
tion and misfolding of the Fab, the e¡ects of GSH, GSSG,
PDI and molecular chaperones were also examined.
To discover the solubility of the synthesized Fab, the reac-
tion mixture was separated by centrifugation into soluble and
insoluble fractions, and analyzed by SDS^PAGE under reduc-
ing conditions and autoradiography. Under this condition,
only two bands of the expected size for the Hc and the Lc
could be seen on the gel (Fig. 6I). To discover the amount of
protein in each fraction, the quantity of radiation of each
band was measured using a FUJIX BAStation (Fig. 6II).
Fig. 3. Autoradiography of the non-reducing SDS^PAGE of Lc, Hc
and Fab of 6D9 synthesized in an E. coli in vitro coupled transcrip-
tion/translation system with the plasmids, pRSET-6D9Lc and
pRSET-6D9Hc. Samples were taken at 60, 120 and 180 min after
the start of incubation.
Fig. 4. Time course of 6D9 Fab synthesized in an E. coli in vitro
coupled transcription/translation system with the plasmids, pRSET-
6D9Lc and pRSET-6D9Hc, under non-reducing conditions. The
samples were taken at the indicated times after the start of incuba-
tion and analyzed by 12.5% SDS^PAGE and autoradiography.
Fig. 5. ELISA analysis of Lc, Hc and Fab of 6D9 synthesized in an
E. coli in vitro coupled transcription/translation system. Samples
were taken at 60 min after the start of incubation.
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The total intensity of the Hc and Lc bands in the reducing gel
shown in Fig. 6I was employed as the amount of the Fab
fragment present in each sample.
Under our standard reaction conditions, about 60% of the
synthesized 6D9 Fab were detected in the soluble fraction.
The addition of GSH, GSSG and PDI increased the solubility
to 70%. In previous studies, the e¡ects of GSH, GSSG and
PDI on the solubility of scFv had been reported [25,26].
It has been shown that molecular chaperone DnaJ and its
cofactor DnaK can facilitate the digestion of unfolded pro-
teins by the ATP-dependent protease [27]. Merk and co-work-
ers also reported that the addition of DnaJ and DnaK in-
creased the solubility of scFv [26]. In this work, however,
the combinations of DnaJ and DnaK showed no further pro-
motion on the Fab solubility. This di¡erence might suggest
that both DnaJ and DnaK families of chaperones bind un-
folded proteins in a selective way, which may be dictated by
the nature of each protein. On the other hand, the addition of
GroEL and its co-chaperone GroES also in£uenced the fold-
ing of the Fab fragment, yielding a further increase in solu-
bility of the Fab fragment by 6%. This result was similar to
the previous report about scFv described by Ryabova et al.
[14].
From the result of Fig. 6I, the addition of GSH, GSSG,
PDI and chaperones also increased the amount of synthesized
Fab fragment because the intensity of the bands representing
both soluble and insoluble fractions became higher. We also
separately examined the e¡ect of GSH/GSSG and PDI. The
GSH/GSSG increased both the amount and the solubility of
synthesized Fab signi¢cantly. The addition of PDI also in-
creased the solubility slightly, but not the amount of the
Fab (data not shown). To make a de¢nite conclusion, how-
ever, it is necessary to determine further the e¡ects of GSH,
GSSG, PDI and chaperones on other proteins.
Fig. 6. E¡ects of GSH, GSSG, PDI and chaperones on the solubility and antigen-binding activity of 6D9 Fab. I: The supernatant (a) and pel-
let (b) fractions of each in vitro coupled transcription/translation mixture were analyzed by 12.5% SDS^PAGE under reduced conditions and
autoradiography. Samples were taken at 60 min after the start of incubation. Sample 1, without addition; sample 2, in the presence of GSH,
GSSG and PDI; sample 3, in the presence of GSH, GSSG, PDI, DnaK and DnaJ; sample 4, in the presence of GSH, GSSG, PDI, DnaK,
DnaJ, GroES and GroEL. II: Percentage of protein in supernatant (close bar) and pellet (open bar) fractions of each sample of I. III: Anti-
gen-binding activity of each sample of I was analyzed by ELISA as described in Section 2.
Fig. 7. SDS^PAGE analysis of IMAC-puri¢ed 6D9 Fab synthesized in an E. coli in vitro coupled transcription/translation system. The gel was
stained with CBB. Lane 1, Fab produced in vivo; lane 2, His-tagged Fab synthesized in vitro; lane 3, His-tagged Hc synthesized in vitro.
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We also examined the e¡ects of GSH, GSSG, PDI and
chaperones on the antigen-binding activity of the Fab frag-
ment. From the result shown in Fig. 6III, the addition of
GSH, GSSG and PDI increased the ELISA signal by 1.6-
fold, and that of GroEL and its co-chaperone GroES also
increased further to 0.2-fold. On the other hand, there was
no in£uence of chaperones DnaJ and DnaK on the ELISA
signal of the Fab fragment. This suggests that the increased
solubility of the synthesized Fab fragment is accompanied by
a signi¢cant increase of antigen-binding activity.
3.4. Catalytic activity of 6D9 Fab fragment synthesized in vitro
To purify the 6D9 Fab fragment, plasmid pET23b-6D9Hc,
possessing the 6D9 Hc fused with 6UHis tag sequences at the
C-terminal part, was used as the template DNA instead. The
pET23b-6D9Hc and pRSET-6D9Lc simultaneously served as
template DNA in the same transcription/translation system as
above. The synthesized His-tagged Fab fragment was puri¢ed
with immobilized metal-ion a⁄nity chromatography and
checked by SDS^PAGE stained with Coomassie brilliant
blue (CBB) (Fig. 7). The His-tagged Fab fragment was de-
tected as a band in the gel with a molecular mass of about 50
kDa. The molecular mass of His-tagged Fab fragment was
slightly higher than that of Fab fragment produced in vivo
with a molecular mass of approximately 48 kDa. The catalytic
activity of the Fab synthesized in vitro was analyzed by
HPLC and shown in Table 1. The speci¢c activity of the
puri¢ed Fab was more than 17 times higher than that of Hc
and similar to that of the authentic Fab produced by hybrid-
oma cells. These results indicate that the Fab synthesized in
vitro had catalytic activity comparable to Fab fragment pro-
duced in vivo.
3.5. Conclusions
In this report we have described a successful synthesis of the
Fab fragment of catalytic antibody 6D9 in the E. coli in vitro
coupled transcription/translation system. This method can
provide us with a novel approach for the expression and
screening of catalytic antibodies to improve their activities.
To our knowledge, this is the ¢rst report of the in vitro syn-
thesis of the Fab fragment retaining speci¢c antigen-binding
a⁄nity and catalytic activity.
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Table 1
Speci¢c activities of proteins synthesized in vivo or in vitro
Protein (derivation) Fab quantity (mg) Activity (units) Speci¢c activity (units/mg)
Fab (in vivo) 19.4U1033 35.2U1036 1.82U1033
Fab (in vitro) 20.0U1033 36.6U1036 1.63U1033
Hc (in vitro) 10.3U1033 0.97U1036 0.09U1033
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